LMU medical scientists have demonstrated that important pro-inflammatory mediators are released into the bloodstream through tiny pores in the cell membrane at a very early stage of the immune response.
Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients – Biotech Investments
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract/Alliance Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment